MediWound Reports First Quarter 2017 Financial Results
May 08, 2017 11:01 am UTC| Business
YAVNE, Israel, May 08, 2017 -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, reports financial...
Epizyme Reports First Quarter 2017 Results and Provides Corporate Update
May 08, 2017 11:01 am UTC| Business
Interim Phase 2 Data of Tazemetostat in Molecularly Defined Solid Tumors and NHL to be Presented at Scientific Meetings in June Conference Call on Interim Solid Tumor Data to be Held on May 18, 2017 Conference Call on...
Epizyme Reports First Quarter 2017 Results and Provides Corporate Update
May 08, 2017 11:01 am UTC| Business
Interim Phase 2 Data of Tazemetostat in Molecularly Defined Solid Tumors and NHL to be Presented at Scientific Meetings in June Conference Call on Interim Solid Tumor Data to be Held on May 18, 2017 Conference Call on...
May 08, 2017 11:01 am UTC| Business
-- First-Quarter 2017 Net Sales of $220.9 Million; Up 8 Percent -- -- First-Quarter 2017 Net Loss of $90.6 Million; Adjusted EBITDA of $51.9 Million -- -- First-Quarter 2017 Net Sales from Rare Disease Medicines...
Platform Specialty Products Corporation Announces First Quarter of 2017 Financial Results
May 08, 2017 11:01 am UTC| Business
WEST PALM BEACH, Fla., May 08, 2017 -- Platform Specialty Products Corporation (NYSE:PAH) (“Platform” or the “Company”), a global, diversified specialty chemicals company, today announced its financial results for the...
Snyder’s-Lance, Inc. Reports First Quarter 2017 Financial Results
May 08, 2017 11:01 am UTC| Business
Total net revenue from continuing operations increased 18.7%, including the contribution of Diamond FoodsSnyder's-Lance legacy net revenue increased 3.3%GAAP earnings per share of $0.11Earnings per share excluding special...
Axsome Therapeutics Receives FDA Fast Track Designation for AXS-05 for Alzheimer’s Disease Agitation
May 08, 2017 11:01 am UTC| Business
NEW YORK, May 08, 2017 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, received Fast Track...
Threading Opportunity: How an India–EU FTA Could Reweave Textile Fortunes